SCHEMBL30283447

SCHEMBL30283447

COc1ccc(OCCC2CCCN(C(=O)OC(C)(C)C)C2)cc1CNC(=O)[C@H](CCc1ccccc1)NC(=O)OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
YAP1 P46937 3/20 0.42
BCHE P06276 4/20 0.42
HTR6 P50406 4/20 0.42
PSMB5 P28074 3/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
ACHE P22303 2/20 0.41
CACNA1F O60840 1/20 0.41
CACNA1D Q01668 1/20 0.41
CACNA1S Q13698 1/20 0.41
CACNA1C Q13936 1/20 0.41
ITGB3 P05106 2/20 0.39
ITGA2B P08514 2/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
P2RX7 Q99572 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29269481 1.00 YAP1 (0.42) YAP1BCHEHTR6PSMB5LMNA
SCHEMBL29269479 1.00 YAP1 (0.42) YAP1BCHEHTR6PSMB5LMNA
SCHEMBL29269320 0.92 BCHE (0.43) YAP1BCHEHTR6PSMB5ACHE
SCHEMBL30283202 0.92 BCHE (0.43) YAP1BCHEHTR6PSMB5ACHE
SCHEMBL29269318 0.92 BCHE (0.43) YAP1BCHEHTR6PSMB5ACHE
SCHEMBL29269492 0.92 YAP1 (0.42) YAP1BCHEHTR6ACHECACNA1F
SCHEMBL30283502 0.92 YAP1 (0.42) YAP1BCHEHTR6ACHECACNA1F
SCHEMBL29269489 0.92 YAP1 (0.42) YAP1BCHEHTR6ACHECACNA1F
SCHEMBL29269487 0.89 BCHE (0.44) YAP1BCHEHTR6ACHECACNA1F
SCHEMBL29269486 0.89 BCHE (0.44) YAP1BCHEHTR6ACHECACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4301736-A1 MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS Lead Discovery Center GmbH (DE) 2024-01-10 EP disclosed
WO-2023046939-A1 MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2023-03-30 WO disclosed